Numerous Humira biosimilars are on the market after AbbVie’s 20-year exclusive on the rheumatoid arthritis biologic, but they aren’t fostering much competition, KFF Health News reported Sept. 19. Nine ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈